| Literature DB >> 15922082 |
Nirmala Bhogal1, Christina Grindon, Robert Combes, Michael Balls.
Abstract
Biotechnology is evolving at a tremendous rate. Although drug discovery is now heavily focused on high throughput and miniaturized screening, the application of these advances to the toxicological assessment of chemicals and chemical products has been slow. Nevertheless, the impending surge in demands for the regulatory toxicity testing of chemicals provides the impetus for the incorporation of novel methodologies into hazard identification and risk assessment. Here, we review the current and likely future value of these new technologies in relation to toxicological evaluation and the protection of human health.Entities:
Mesh:
Year: 2005 PMID: 15922082 DOI: 10.1016/j.tibtech.2005.04.006
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536